SCHEMBL11077800

SCHEMBL11077800

CCCCOC(=O)C1(CCCOCCCC2CCCC2)CO1

nearest known ligand 0.45

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ABCB11 O95342 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
MAPK1 P28482 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
CYP1A2 P05177 1/20 0.38
NAAA Q02083 4/20 0.38
FKBP1A P62942 3/20 0.37
EPHX1 P07099 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11070504 0.94 SMN1; SMN2 (0.41) ABCB11SMN1; SMN2CYP1A2NAAAFKBP1A
SCHEMBL11077615 0.92 CYP1A2 (0.44) ABCB11LMNAMAPTMAPK1SMN1; SMN2
SCHEMBL11071475 0.90 ABCB11 (0.45) ABCB11LMNAMAPTMAPK1SMN1; SMN2
SCHEMBL11076758 0.90 ABCB11 (0.47) ABCB11LMNAMAPTMAPK1NAAA
SCHEMBL11078384 0.90 ABCB11 (0.44) ABCB11LMNAMAPTMAPK1SMN1; SMN2
SCHEMBL11068114 0.89 ABCB11 (0.41) ABCB11LMNAMAPTMAPK1SMN1; SMN2
SCHEMBL11075284 0.84 ABCB11 (0.39) ABCB11LMNAMAPTMAPK1CYP1A2
SCHEMBL11080350 0.84 ABCB11 (0.44) ABCB11LMNAMAPTMAPK1
SCHEMBL11073284 0.84 MAPT (0.46) ABCB11LMNAMAPTMAPK1SMN1; SMN2
SCHEMBL11071844 0.84 ABCB11 (0.43) ABCB11LMNAMAPTMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4430339-A PROPHYLAXIS, METABOLISM, GLUCOSE, FATS, HYPOGLYCEMIC AGENTS BYK GULDEN LOMBERG CHEMISCHE FABRIK GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1984-02-07 US disclosed
WO-1982000822-A1 SUBSTITUTED OXIRANECARBOXYLIC ACIDS,THEIR PREPARATION AND THEIR USE AS MEDICAMENTS EISTETTER K 1982-03-18 WO disclosed